Vimarsana
Biggest News Aggregation in the World

Page 3 - Current Concepts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Concepts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Concepts Today - Breaking & Trending Today

Are Eggs Inflammatory? Read The Answer To Know In [UK] 2023 - Vimarsana News

Are Eggs Inflammatory? Read The Answer To Know In [UK] 2023

Are eggs inflammatory? Discover the facts and science behind eggs, their benefits, and their connection to inflammation in the body in 2023.

Are Eggs Inflammatory? Read The Answer To Know In [AU] 2023 - Vimarsana News

Are Eggs Inflammatory? Read The Answer To Know In [AU] 2023

Are eggs inflammatory? Discover the facts and science behind eggs, their benefits, and their connection to inflammation in the body in 2023.

Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure - Vimarsana News

Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

Injectafer is an intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency 

FDA Approves Intravenous Iron Replacement Therapy for Heart Failure Patients - Vimarsana News

FDA Approves Intravenous Iron Replacement Therapy for Heart Failure Patients

Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity. The company reported that with this approval, INJECTAFER is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency.

INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure - Vimarsana News

INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

INJECTAFER is now the first and only intravenous iron replacement therapy indicated for adult patients with heart failure who have iron deficiency ... | June 5, 2023